Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.
Epidemiological studies have shown that the regular use of non-steroidal anti-inflammatory (NSAIDs) drugs is associated with a reduced risk of various cancers. In addition, in vitro and experiments in mouse models have demonstrated that NSAIDs decrease tumor initiation and/or progression of several...
Main Authors: | Blanca L Valle, Theresa D'Souza, Kevin G Becker, William H Wood, Yongqing Zhang, Robert P Wersto, Patrice J Morin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3634839?pdf=render |
Similar Items
-
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
by: Sherman-Baust Cheryl A, et al.
Published: (2011-12-01) -
Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.
by: Neetu Dahiya, et al.
Published: (2011-01-01) -
The clinical and morphological features of ovarian steroid cell tumors
by: E. V. Cherepanova, et al.
Published: (2014-08-01) -
MicroRNA expression and identification of putative miRNA targets in ovarian cancer.
by: Neetu Dahiya, et al.
Published: (2008-06-01) -
Ovarian Steroid Cell Tumor (Not Otherwise Specified): A Case Report of Ovarian Hyperandrogenism
by: Hadjkacem Faten, et al.
Published: (2020-01-01)